The European Commission and its Scientific Committee on Health, Environmental and Emerging Risks (SCHEER) have published two Scientific Advices related to breast implants and health, requested by the European Commission. These are on:
1) new scientific information on the safety of PIP breast implants
The first piece of advice concerns whether there is sufficient new scientific information on the safety of PIP breast implants to warrant an update of the 2014 SCENIHR Opinion. Based on the scientific information it has gathered and evaluated, the SCHEER concludes that this is not the case at present
2) the possible association between breast implants and anaplastic large cell lymphoma (ALCL).
The second piece of advice is on the state of scientific knowledge on a possible association between breast implants and anaplastic large cell lymphoma. The SCHEER concluded that, at present, there is insufficient scientific information available to establish a methodologically robust risk assessment on the potential association of breast implants with the development of ALCL.
To read the full report and advice on the European Commission website go to: http://ec.europa.eu/newsroom/sante/newsletter-specific-archive-issue.cfm?newsletter_service_id=327&newsletter_issue_id=3209